Clinical Trials Directory

Trials / Unknown

UnknownNCT03941366

Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders

Treatment of T2-T3/NO-N+ Adenocarcinoma of the Rectum by Neoadjuvant Chemotherapy (FOLFOX) Followed by Preoperative Chemo (5FU/Capecitabine)-Radio Therapy (CRT) With Transanal Local Excision for Complete Responders

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The current standard of care for rectal cancer has diminished local recurrence and enhanced survival. Quality of life, however, remains poor for many patients and the probability of distant recurrence is high. In this study, we will attempt to reduce the distant recurrence rate and improve quality of life by making changes in the timing and administration of chemotherapy and radiation and doing less invasive rectal surgery when indicated.

Detailed description

The purpose of the study is to determine if neo-adjuvant FOLFOX therapy and lengthening the time interval between neo-adjuvant chemotherapy and transanal local excision will increase the percentage of patients with pathologic complete remission. This is a prospective pilot study to examine the impact of two variables: 1) addition of neo-adjuvant FOLFOX chemotherapy, and 2) increasing the time interval between completion of chemo-radiotherapy and subsequent surgery, on the rate of achieving pathologic complete remission with avoidance of radical resection while maintaining an excellent local control with improvement of quality of life. All procedures in this study are standard of care, the study question relates to the use of neo-adjuvant FOLFOX and the timing between the end of radiation and surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard of care chemotherapy with the change for avoidance of extensive surgeryAll treatments (chemotherapy, radiation, surgery) are standard of care; however, the timing of the procedures is altered to allow for the possibility of local excision instead of more extensive surgery.

Timeline

Start date
2016-02-26
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2019-05-07
Last updated
2023-01-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03941366. Inclusion in this directory is not an endorsement.

Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders (NCT03941366) · Clinical Trials Directory